Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial (vol 21, pg 1099, 2022)

被引：0
|
作者：
Soileau, M. J.
Aldread, J.
Budur, K.
机构：
来源：
LANCET NEUROLOGY | 2023年 / 22卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：E5 / E5
页数：1
相关论文
共 50 条
  • [1] Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial
    Soileau, Michael J.
    Aldred, Jason
    Budur, Kumar
    Fisseha, Nahome
    Fung, Victor Sc
    Jeong, Anna
    Kimber, Thomas E.
    Klos, Kevin
    Litvan, Irene
    O'Neill, Daniel
    Robieson, Weining Z.
    Spindler, Meredith A.
    Standaert, David G.
    Talapala, Saritha
    Vaou, Eleni Okeanis
    Zheng, Hui
    Facheris, Maurizio F.
    Hauser, Robert A.
    LANCET NEUROLOGY, 2022, 21 (12) : 1099 - 1109
  • [2] Subcutaneous foslevodopa/foscarbidopa in patients with advanced Parkinson's Disease: results from a randomized, double-blind, double-dummy phase 3 trial
    Soileau, M.
    Spindler, M.
    Aldred, J.
    Budur, K.
    Fisseha, N.
    Fung, V.
    Jeong, A.
    Kimber, T.
    Klos, K.
    Litvan, I.
    O'Neill, D.
    Robieson, W.
    Standaert, D.
    Talapala, S.
    Vaou, E. Okeanis
    Zheng, H.
    Facheris, M.
    Hauser, R.
    MOVEMENT DISORDERS, 2022, 37 : S354 - S354
  • [3] Efficacy and safety of foslevodopa/foscarbidopa versus oral carbidopa/levodopa in advanced Parkinson's disease patients: Design of a phase 3, randomized, double-blind, double-dummy, active controlled 12-week trial
    Facheris, Maurizio
    Robieson, Weining
    Fisseha, Nahome
    Standaert, David
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 331 - 331
  • [4] Efficacy and Safety of Foslevodopa/Foscarbidopa Versus Oral Carbidopa/Levodopa in Advanced Parkinson's Disease Patients: Design of a Phase 3, Randomized, Double-Blind, Double-Dummy, Active Controlled 12-Week Trial
    Facheris, Maurizio
    Robieson, Weining
    Fisseha, Nahome
    Standaert, David
    NEUROLOGY, 2021, 96 (15)
  • [5] Efficacy and Safety of Foslevodopa/Foscarbidopa Continuous Subcutaneous Infusion Administered as Monotherapy in Patients with Parkinson's Disease
    Aldred, J.
    Henriksen, T.
    Bouchard, M.
    Martinez-Castrillo, J.
    Soileau, M.
    Spiegel, A.
    Bergmann, L.
    Gupta, R.
    Kukreja, P.
    Standaert, D.
    MOVEMENT DISORDERS, 2023, 38 : S7 - S8
  • [6] EFFICACY AND SAFETY OF FOSLEVODOPA/FOSCARBIDOPA CONTINUOUS SUBCUTANEOUS INFUSION ADMINISTERED AS MONOTHERAPY IN PATIENTS WITH PARKINSON'S DISEASE
    Aldred, J.
    Henriksen, T.
    Bouchard, M.
    Martinez-Castrillo, J. C.
    Soileau, M. J.
    Spiegel, A.
    Bergmann, L.
    Gupta, R.
    Kukreja, P.
    Standaert, D. G.
    PARKINSONISM & RELATED DISORDERS, 2024, 122
  • [7] A Post Hoc Efficacy Analysis of Phase 3 Trials of Continuous Subcutaneous Foslevodopa/Foscarbidopa in Patients With Parkinson's disease (PD)
    Soileau, M.
    Bouchard, M.
    Malaty, I.
    Parra, J.
    Bergmann, L.
    Gupta, R.
    Spiegel, A.
    Freire-Alvarez, E.
    MOVEMENT DISORDERS, 2024, 39 : S333 - S334
  • [8] Randomised clinical trial: A double-blind, randomised, active-controlled, phase 3 study to evaluate the safety and efficacy of Tegoprazan in patients with gastric ulcer
    Choe, YoungHee
    Cho, YuKyung
    Lim, ChulHyun
    Choi, Myung-Gyu
    NEUROGASTROENTEROLOGY AND MOTILITY, 2020, 32
  • [9] BOUNDLESS: AN ACTIVE-CONTROLLED, RANDOMISED, DOUBLE-BLIND, DOUBLE-DUMMY TRIAL OF CONTINUOUS SUBCUTANEOUS INFUSION OF LEVODOPA/CARBIDOPA WITH ND0612 IN PATIENTS WITH PARKINSON'S DISEASE
    Rascol, O.
    Poewe, W.
    Stocchi, F.
    Yardeni, T.
    Barak, S. Leibman
    Adar, L.
    Rosenfeld, O.
    Olanow, C. W.
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : E53 - E53
  • [10] Continuous Subcutaneous Foslevodopa/Foscarbidopa in Advanced Parkinson's Disease: Results From a 12-Month Phase 3 Study
    Aldred, J.
    Amelin, A.
    Antonini, A.
    Bergmans, B.
    Bergquist, F.
    Bouchard, M.
    Budur, K.
    Carroll, C.
    Chaudhuri, K.
    Criswell, S.
    Danielsen, E.
    Alvarez, E. Freire
    Gandor, F.
    Jia, J.
    Kimber, T.
    Mochizuki, H.
    Robieson, W.
    Spiegel, A.
    Standaert, D.
    Talapala, S.
    Facheris, M.
    Fung, V.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 178 - 179
12345